These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18250975)

  • 21. Regenerative and immunomodulatory potential of mesenchymal stem cells.
    Krampera M; Pasini A; Pizzolo G; Cosmi L; Romagnani S; Annunziato F
    Curr Opin Pharmacol; 2006 Aug; 6(4):435-41. PubMed ID: 16777484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
    Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
    Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
    Stagg J; Galipeau J
    Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
    Zhao ZG; Li WM; Chen ZC; You Y; Zou P
    Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
    Müller I; Lymperi S; Dazzi F
    Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene.
    Guo X; Zheng Q; Yang S; Shao Z; Yuan Q; Pan Z; Tang S; Liu K; Quan D
    Biomed Mater; 2006 Dec; 1(4):206-15. PubMed ID: 18458408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a role for mesenchymal stem cells in autoimmune diseases?
    Uccelli A; Mancardi G; Chiesa S
    Autoimmunity; 2008 Dec; 41(8):592-5. PubMed ID: 18958745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cells for clinical application.
    Sensebé L; Krampera M; Schrezenmeier H; Bourin P; Giordano R
    Vox Sang; 2010 Feb; 98(2):93-107. PubMed ID: 19663934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
    Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
    Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood.
    Kögler G; Sensken S; Wernet P
    Exp Hematol; 2006 Nov; 34(11):1589-95. PubMed ID: 17046580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cell homing capacity.
    Sordi V
    Transplantation; 2009 May; 87(9 Suppl):S42-5. PubMed ID: 19424004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.
    Urbán VS; Kiss J; Kovács J; Gócza E; Vas V; Monostori E; Uher F
    Stem Cells; 2008 Jan; 26(1):244-53. PubMed ID: 17932424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of EGFP-labeled mesenchymal stem cells and redistribution of allogeneic cells after subcutaneous implantation.
    Duan X; Yang L; Dong S; Xin R; Chen G; Guo L
    Arch Orthop Trauma Surg; 2008 Jul; 128(7):751-9. PubMed ID: 18265994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune effects of mesenchymal stem cells: implications for Charcot-Marie-Tooth disease.
    Leal A; Ichim TE; Marleau AM; Lara F; Kaushal S; Riordan NH
    Cell Immunol; 2008; 253(1-2):11-5. PubMed ID: 18627903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ear mesenchymal stem cells: an efficient adult multipotent cell population fit for rapid and scalable expansion.
    Sart S; Schneider YJ; Agathos SN
    J Biotechnol; 2009 Feb; 139(4):291-9. PubMed ID: 19136033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
    Giordano A; Galderisi U; Marino IR
    J Cell Physiol; 2007 Apr; 211(1):27-35. PubMed ID: 17226788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.